Seroprevalence of hepatitis E virus among pregnant women and control subjects in China

Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV‐endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 an...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 87; no. 3; pp. 446 - 450
Main Authors Cong, Wei, Sui, Jian-Chao, Zhang, Xiang-Yan, Qian, Ai-Dong, Chen, Jia, Zhu, Xing-Quan
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV‐endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case‐control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine‐hundred and ninety pregnant women who visited hospitals for antenatal follow‐up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti‐HEV IgG and IgM antibodies by enzyme immunoassays. Socio‐demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti‐HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti‐HEV IgG positive whereas, in control subjects 25.3% of samples were anti‐HEV IgG positive, (P < 0.01). For anti‐HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446–450, 2015. © 2014 Wiley Periodicals, Inc.
AbstractList Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P<0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446-450, 2015. copyright 2014 Wiley Periodicals, Inc.
Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China.
Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China.Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P < 0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China.
Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women. China is generally judged to be an HEV-endemic area, but epidemiological data for HEV among pregnant women are limited. Between June 2011 and July 2013, a case-control study was conducted to estimate the seroprevalence and potential risk factors associated with the acquisition of HEV infection by pregnant women in China. Nine-hundred and ninety pregnant women who visited hospitals for antenatal follow-up or medication in Qingdao and Weihai and 965 control subjects matched by age, gender and residence were examined for the presence of anti-HEV IgG and IgM antibodies by enzyme immunoassays. Socio-demographic and behavioral characteristics from the study subjects were obtained. The overall prevalence of anti-HEV IgG in all 1,955 samples was 20.7%. In pregnant women, 16.2% of samples were anti-HEV IgG positive whereas, in control subjects 25.3% of samples were anti-HEV IgG positive, (P<0.01). For anti-HEV IgM detection, 62 (3.2%) of the 1,955 serum samples were positive and the seroprevalence in pregnant women and control subjects was 2.6% and 3.6%, respectively. Age, contact with cats, contact with pigs and exposure to soil were found to be associated with HEV infection. These findings demonstrated the high prevalence of HEV and the considerable potential for the transmission of HEV infection in pregnant women in China. J. Med. Virol. 87:446-450, 2015. © 2014 Wiley Periodicals, Inc.
Author Chen, Jia
Cong, Wei
Sui, Jian-Chao
Zhu, Xing-Quan
Qian, Ai-Dong
Zhang, Xiang-Yan
Author_xml – sequence: 1
  givenname: Wei
  surname: Cong
  fullname: Cong, Wei
  organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, China
– sequence: 2
  givenname: Jian-Chao
  surname: Sui
  fullname: Sui, Jian-Chao
  organization: Weihai Wendeng Central Hospital, Weihai, Shandong Province, China
– sequence: 3
  givenname: Xiang-Yan
  surname: Zhang
  fullname: Zhang, Xiang-Yan
  organization: Affilliated Hospital of Medical College, Qingdao University, Shandong Province, Qingdao, China
– sequence: 4
  givenname: Ai-Dong
  surname: Qian
  fullname: Qian, Ai-Dong
  organization: College of Animal Science and Technology, Jilin Agricultural University, Jilin Province, Changchun, China
– sequence: 5
  givenname: Jia
  surname: Chen
  fullname: Chen, Jia
  organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Gansu Province, Lanzhou, China
– sequence: 6
  givenname: Xing-Quan
  surname: Zhu
  fullname: Zhu, Xing-Quan
  email: Correspondence to: Xing-Quan Zhu, State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 1 Xujiaping, Yanchangbu, Lanzhou, Gansu Province 730046, China., zhuxingquan@caas.cn
  organization: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25164987$$D View this record in MEDLINE/PubMed
BookMark eNqN0U1PFTEYBeDGYOSCLvwDpokbXQy87fRjupQbBAz4ERESN02n04FeZ9prO3OBf-_ABRYkGlfdPOdNes4W2ggxOIReE9ghAHR30a92KANePUMzAkoUCiTZQDMgTBRCEL6JtnJeAEClKH2BNikngqlKztDZd5fiMrmV6VywDscWX7qlGfzgM97HK5_GjE0fwwWe1EUwYcBXsXcBm9BgG8OQYofzWC-cHTL2Ac8vfTAv0fPWdNm9un-30Y-P-6fzw-L4y8HR_MNxYZliVWEMhaZVkpaGK2jAKlkz5tqmbpwSYBkFaErDqpZQWnMlGt6W0qrK1txVRpbb6N367jLF36PLg-59tq7rTHBxzJoIzkRVKkX_h04dAhdsom-f0EUcU5g-MikmpFTiTr25V2Pdu0Yvk-9NutEP5U7g_RrYFHNOrn0kBPTtcHoaTt8NN9ndJ9b6YZrhtmDju38lrnznbv5-Wn86OXtIFOuEz4O7fkyY9EsLWUquzz8f6D04_Hb-8_REfy3_AKZqt5o
CitedBy_id crossref_primary_10_5144_0256_4947_2020_136
crossref_primary_10_18632_oncotarget_23381
crossref_primary_10_1186_s12884_020_03116_2
crossref_primary_10_1371_journal_pone_0238987
crossref_primary_10_1016_S2468_1253_19_30342_5
crossref_primary_10_1080_22221751_2023_2276336
crossref_primary_10_1016_j_actatropica_2017_04_033
crossref_primary_10_1016_j_flm_2018_11_003
crossref_primary_10_1016_j_actatropica_2019_02_004
crossref_primary_10_1016_j_vaccine_2019_08_003
crossref_primary_10_1186_s12985_021_01616_x
crossref_primary_10_1016_j_bjid_2015_08_009
crossref_primary_10_1007_s40572_016_0096_x
crossref_primary_10_1002_jmv_24203
crossref_primary_10_1186_s12985_024_02576_8
crossref_primary_10_1016_j_rvsc_2024_105429
crossref_primary_10_3390_healthcare9020133
crossref_primary_10_3390_pathogens12091072
crossref_primary_10_1080_14767058_2019_1582630
crossref_primary_10_1080_14767058_2020_1852206
crossref_primary_10_1002_jmv_24693
crossref_primary_10_1002_jmv_24871
crossref_primary_10_1155_2017_4067108
crossref_primary_10_1186_s12879_015_1308_y
crossref_primary_10_1016_j_jcv_2016_07_010
crossref_primary_10_1186_s12985_020_01343_9
crossref_primary_10_1111_tbed_14437
Cites_doi 10.1186/1743-422X-5-158
10.1016/j.jhep.2007.12.008
10.1016/j.jviromet.2009.11.028
10.1186/1756-0500-3-103
10.1002/jmv.23804
10.1186/1743-422X-6-108
10.3201/eid1712.110371
10.3201/eid1112.051041
10.1016/j.jcv.2013.08.030
10.1016/j.ijid.2012.11.026
10.1002/jmv.21033
10.1002/jmv.23429
10.1007/BF02722743
10.1128/JCM.01466-09
10.3201/eid1809.120241
10.1371/journal.pone.0061351
10.1093/infdis/jit409
10.1016/j.bjid.2013.02.006
10.5812/hepatmon.6194
ContentType Journal Article
Copyright 2014 Wiley Periodicals, Inc.
Copyright_xml – notice: 2014 Wiley Periodicals, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
7T2
7U1
DOI 10.1002/jmv.24058
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Health and Safety Science Abstracts (Full archive)
Risk Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
Risk Abstracts
Health & Safety Science Abstracts
DatabaseTitleList Risk Abstracts
MEDLINE
MEDLINE - Academic
Genetics Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9071
EndPage 450
ExternalDocumentID 3562643941
25164987
10_1002_jmv_24058
JMV24058
ark_67375_WNG_B0HQWZTM_P
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
China, People's Rep., Shandong Prov., Qingdao
China, People's Rep., Shandong Prov., Weihai
GeographicLocations_xml – name: China
– name: China, People's Rep., Shandong Prov., Weihai
– name: China, People's Rep., Shandong Prov., Qingdao
GrantInformation_xml – fundername: Science Fund for Creative Research Groups of Gansu Province
  funderid: 1210RJIA006
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECGQY
EJD
ELTNK
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
VH1
W8V
W99
WBKPD
WHG
WIB
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
7T2
7U1
ID FETCH-LOGICAL-c4948-aa20df9723a590d0c97b44efdbde960c4200d3a48f122b596d5f37c98cb5e8a73
IEDL.DBID DR2
ISSN 0146-6615
1096-9071
IngestDate Fri Jul 11 12:43:02 EDT 2025
Fri Jul 11 11:56:03 EDT 2025
Sat Jul 26 02:14:47 EDT 2025
Mon Jul 21 06:06:28 EDT 2025
Tue Jul 01 02:24:33 EDT 2025
Thu Apr 24 22:51:15 EDT 2025
Wed Aug 20 07:25:54 EDT 2025
Wed Oct 30 09:56:13 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords seroprevalence
pregnant women
control subjects
Hepatitis E Virus
China
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2014 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4948-aa20df9723a590d0c97b44efdbde960c4200d3a48f122b596d5f37c98cb5e8a73
Notes ark:/67375/WNG-B0HQWZTM-P
Science Fund for Creative Research Groups of Gansu Province - No. 1210RJIA006
ArticleID:JMV24058
istex:00BD35E9E011B36B9382F899FF07D087300FC562
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25164987
PQID 1646779664
PQPubID 105515
PageCount 5
ParticipantIDs proquest_miscellaneous_1654683992
proquest_miscellaneous_1652400564
proquest_journals_1646779664
pubmed_primary_25164987
crossref_primary_10_1002_jmv_24058
crossref_citationtrail_10_1002_jmv_24058
wiley_primary_10_1002_jmv_24058_JMV24058
istex_primary_ark_67375_WNG_B0HQWZTM_P
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2015
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: March 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Journal of medical virology
PublicationTitleAlternate J. Med. Virol
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. 2009. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 6:108.
Dong C, Dai X, Liang J, Dong M, Meng J. 2012. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon 12:386-390.
Caron M, Kazanji M. 2008. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 5:158.
Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. 2010. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 48:317-318.
Goumba CM, Yandoko-Nakouné ER, Komas NP. 2010. A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes 3:103.
Pelosi E, Clarke I. 2008. Hepatitis E: A complex and global disease. Emerg Health Threats J 1:e8.
Huang F, Ma T, Li L, Zeng W, Jing S. 2013. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis 17:16-17.
Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, Choutet P, Garcia-Bonnet N, Coursaget P. 2013. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 58:504-508.
Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE. 2012. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 18:1401-1404.
Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. 2003. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 70:3739.
Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. 2014. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 86:71-74.
Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11:1958-11960.
Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: The current scenario. Int J Infect Dis 17: e 228-233.
Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE. 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8:61351.
Bigaillon C, Tessé S, Lagathu G, Nicand E. 2010. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 164:127-130.
Purcell RH, Emerson SU. 2008. Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503.
Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80:95-101.
Chiu DM, Chan MC, Yeung AC, Ngai KL, Chan PK. 2013. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009. J Med Virol 85:459-461.
Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. 2014. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy. J Infect Dis 209:652-657.
Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-23012.
2013; 58
2010; 48
2013; 17
2014; 209
2003; 70
2013; 85
2008; 48
2010; 164
2008; 5
2012; 18
2009; 6
2010; 3
2011; 17
2008; 1
2013; 8
2012; 12
2005; 11
2008; 80
2014; 86
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_21_1
e_1_2_7_20_1
Pelosi E (e_1_2_7_19_1) 2008; 1
References_xml – reference: Chiu DM, Chan MC, Yeung AC, Ngai KL, Chan PK. 2013. Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009. J Med Virol 85:459-461.
– reference: Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE. 2012. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 18:1401-1404.
– reference: Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. 2010. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 48:317-318.
– reference: Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Kmush B, Nelson KE. 2013. An exploratory case control study of risk factors for hepatitis E in rural Bangladesh. PLoS One 8:61351.
– reference: Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T. 2005. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11:1958-11960.
– reference: Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. 2003. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 70:3739.
– reference: Dong C, Dai X, Liang J, Dong M, Meng J. 2012. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon 12:386-390.
– reference: Pelosi E, Clarke I. 2008. Hepatitis E: A complex and global disease. Emerg Health Threats J 1:e8.
– reference: Bigaillon C, Tessé S, Lagathu G, Nicand E. 2010. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 164:127-130.
– reference: Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-23012.
– reference: Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galán JC, Moreno A, Pérez-Gracia MT. 2014. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 86:71-74.
– reference: Chaussade H, Rigaud E, Allix A, Carpentier A, Touzé A, Delzescaux D, Choutet P, Garcia-Bonnet N, Coursaget P. 2013. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 58:504-508.
– reference: Huang F, Ma T, Li L, Zeng W, Jing S. 2013. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis 17:16-17.
– reference: Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Ijaz S, Kelly P. 2014. Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy. J Infect Dis 209:652-657.
– reference: Purcell RH, Emerson SU. 2008. Hepatitis E: an emerging awareness of an old disease. J Hepatol 48:494-503.
– reference: Goumba CM, Yandoko-Nakouné ER, Komas NP. 2010. A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes 3:103.
– reference: Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 80:95-101.
– reference: Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: The current scenario. Int J Infect Dis 17: e 228-233.
– reference: Caron M, Kazanji M. 2008. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 5:158.
– reference: Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. 2009. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 6:108.
– volume: 17
  start-page: 2309
  year: 2011
  end-page: 23012
  article-title: Hepatitis E virus antibodies in blood donors, France
  publication-title: Emerg Infect Dis
– volume: 17
  start-page: 228
  year: 2013
  end-page: 233
  article-title: Hepatitis E virus: The current scenario
  publication-title: Int J Infect Dis
– volume: 8
  start-page: 61351
  year: 2013
  article-title: An exploratory case control study of risk factors for hepatitis E in rural Bangladesh
  publication-title: PLoS One
– volume: 86
  start-page: 71
  year: 2014
  end-page: 74
  article-title: Patients infected with HIV are at high‐risk for hepatitis E virus infection in Spain
  publication-title: J Med Virol
– volume: 17
  start-page: 16
  year: 2013
  end-page: 17
  article-title: Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China
  publication-title: Braz J Infect Dis
– volume: 48
  start-page: 494
  year: 2008
  end-page: 503
  article-title: Hepatitis E: an emerging awareness of an old disease
  publication-title: J Hepatol
– volume: 3
  start-page: 103
  year: 2010
  article-title: A fatal case of acute hepatitis E among pregnant women, Central African Republic
  publication-title: BMC Res Notes
– volume: 58
  start-page: 504
  year: 2013
  end-page: 508
  article-title: Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals
  publication-title: J Clin Virol
– volume: 85
  start-page: 459
  year: 2013
  end-page: 461
  article-title: Seroprevalence of hepatitis E virus in Hong Kong, 2008‐2009
  publication-title: J Med Virol
– volume: 209
  start-page: 652
  year: 2014
  end-page: 657
  article-title: Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy
  publication-title: J Infect Dis
– volume: 6
  start-page: 108
  year: 2009
  article-title: Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana
  publication-title: Virol J
– volume: 70
  start-page: 3739
  year: 2003
  article-title: Mother‐to‐child transmission of hepatitis E virus infection
  publication-title: Indian J Pediatr
– volume: 48
  start-page: 317
  year: 2010
  end-page: 318
  article-title: Prevalence of hepatitis E virus in Chinese blood donors
  publication-title: J Clin Microbiol
– volume: 164
  start-page: 127
  year: 2010
  end-page: 130
  article-title: Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection
  publication-title: J Virol Methods
– volume: 5
  start-page: 158
  year: 2008
  article-title: Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas
  publication-title: Virol J
– volume: 11
  start-page: 1958
  year: 2005
  end-page: 11960
  article-title: Hepatitis E virus transmission from wild boar meat
  publication-title: Emerg Infect Dis
– volume: 18
  start-page: 1401
  year: 2012
  end-page: 1404
  article-title: Hepatitis E, a vaccine‐preventable cause of maternal deaths
  publication-title: Emerg Infect Dis
– volume: 1
  start-page: e8
  year: 2008
  article-title: Hepatitis E: A complex and global disease
  publication-title: Emerg Health Threats J
– volume: 12
  start-page: 386
  year: 2012
  end-page: 390
  article-title: Seroprevalence of hepatitis e virus varies considerably among chinese provinces
  publication-title: Hepat Mon
– volume: 80
  start-page: 95
  year: 2008
  end-page: 101
  article-title: Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response
  publication-title: J Med Virol
– ident: e_1_2_7_5_1
  doi: 10.1186/1743-422X-5-158
– ident: e_1_2_7_20_1
  doi: 10.1016/j.jhep.2007.12.008
– ident: e_1_2_7_4_1
  doi: 10.1016/j.jviromet.2009.11.028
– ident: e_1_2_7_9_1
  doi: 10.1186/1756-0500-3-103
– ident: e_1_2_7_18_1
  doi: 10.1002/jmv.23804
– ident: e_1_2_7_2_1
  doi: 10.1186/1743-422X-6-108
– volume: 1
  start-page: e8
  year: 2008
  ident: e_1_2_7_19_1
  article-title: Hepatitis E: A complex and global disease
  publication-title: Emerg Health Threats J
– ident: e_1_2_7_17_1
  doi: 10.3201/eid1712.110371
– ident: e_1_2_7_16_1
  doi: 10.3201/eid1112.051041
– ident: e_1_2_7_6_1
  doi: 10.1016/j.jcv.2013.08.030
– ident: e_1_2_7_13_1
  doi: 10.1016/j.ijid.2012.11.026
– ident: e_1_2_7_3_1
  doi: 10.1002/jmv.21033
– ident: e_1_2_7_7_1
  doi: 10.1002/jmv.23429
– ident: e_1_2_7_21_1
  doi: 10.1007/BF02722743
– ident: e_1_2_7_10_1
  doi: 10.1128/JCM.01466-09
– ident: e_1_2_7_14_1
  doi: 10.3201/eid1809.120241
– ident: e_1_2_7_15_1
  doi: 10.1371/journal.pone.0061351
– ident: e_1_2_7_12_1
  doi: 10.1093/infdis/jit409
– ident: e_1_2_7_11_1
  doi: 10.1016/j.bjid.2013.02.006
– ident: e_1_2_7_8_1
  doi: 10.5812/hepatmon.6194
SSID ssj0008922
Score 2.2535543
Snippet Hepatitis E infection, caused by the hepatitis E virus (HEV), is an important global public health concern, with particularly high mortality in pregnant women....
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 446
SubjectTerms Adolescent
Adult
Animals
Case-Control Studies
China
China - epidemiology
control subjects
Disease transmission
Environmental Exposure
Enzyme-Linked Immunosorbent Assay
Female
Hepatitis
Hepatitis Antibodies - blood
Hepatitis E - epidemiology
Hepatitis E Virus
Hepatitis E virus - immunology
Humans
Immunoglobulin G - blood
Immunoglobulin M - blood
Pets
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Pregnant Women
Risk Factors
Seroepidemiologic Studies
seroprevalence
Virology
Young Adult
Title Seroprevalence of hepatitis E virus among pregnant women and control subjects in China
URI https://api.istex.fr/ark:/67375/WNG-B0HQWZTM-P/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.24058
https://www.ncbi.nlm.nih.gov/pubmed/25164987
https://www.proquest.com/docview/1646779664
https://www.proquest.com/docview/1652400564
https://www.proquest.com/docview/1654683992
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFA6lgvji_TK2ShQRX2Y7m0kmCX1SaV0KW1R6Q4SQ2-i2dbbs7JTirzcncymViuLbwJyBXM518uU7CL0i49xl2oXqhIhQoBBiU50LmjLpObTFEUTCfefpbjHZpztH7GgFbfZ3YVp-iOGHG1hG9Ndg4NrUG5ekocc_zkchHDG46AtYLUiIPl9SRwnZniAET5CGGMR6VqGMbAxfXolFN2BZL65LNK_mrTHwbN9BX_sht3iTk1GzNCP78zc2x_-c0110u0tI8dtWg-6hFV_dRzen3ZH7A3QQvAl0SgkaCU4Az0v83QMMezmr8RY-ny2aGseWRThIfQNcDY60DlhXDndIeFw3Bn741HhW4diy-yHa397aez9Ju2YMqQUGmVRrkrkSepRpJjOXWckNpb50xvlQBVkazM3lmopyTIhhsnCszLmVwhrmheb5I7RazSv_BOFi7LQljnojGbU8k5ZT7zNPuSmMGBcJetNvi7IdUzk0zDhVLccyUWGdVFynBL0cRM9aeo7rhF7HvR0k9OIE8GycqcPdD-pdNvl0-GVvqj4maL3ffNWZcq2AgI3zUBXSBL0YXgcjhJMVXfl5AzIMsLjsLzK0EMADnKDHrWINAwpJZkGl4GHmUT3-PBe1Mz2ID0__XXQN3QppHmuRc-todblo_LOQSi3N82gzvwB3yxhM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ta9QwGA9zA90X33XVqVFE_NJbL02aBPyisnnO9VC5vSBISJNUz2lPrtch_vXmSXsdk4nit0KfQpM8r8mT3w-hx2SY2kRbX50Q4QsUQkysU0FjJh0HWhxBJNx3zsfZaJ_uHrGjFfRseRemxYfoN9zAMoK_BgOHDemtU9TQL99OBj4eMXEBrQGjdyio3p-CRwnZniF4XxD7KMSWuEIJ2eo_PRON1mBif5yXap7NXEPo2bmCPi5_uu04OR40i2Jgfv6G5_i_o7qKLnc5KX7eKtE1tOKq6-hi3p2630AH3qEAWYpXSvADeFbizw46sRfTGm_jk-m8qXFgLcJe6hO01uCA7IB1ZXHXDI_rpoA9nxpPKxxYu2-i_Z3tyctR3PExxAZAZGKtSWJLoCnTTCY2MZIXlLrSFtb5QshQb3E21VSUQ0IKJjPLypQbKUzBnNA8vYVWq1nlNhDOhlYbYqkrJKOGJ9Jw6lziKC-yQgyzCD1drosyHVg5cGZ8VS3MMlF-nlSYpwg96kW_twgd5wk9CYvbS-j5MbS0caYOx6_Ui2T07vDDJFdvI7S5XH3VWXOtAIONc18Y0gg97F97O4TDFV25WQMyDNpx2V9kaCYACjhCt1vN6n_I55kZlYL7kQf9-PNY1G5-EB7u_LvoA3RpNMn31N7r8Zu7aN1nfaxtpNtEq4t54-75zGpR3A8G9AvoHxxn
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UFoov3i_RqqOI-JJtdjKTmcEntV3X6i5VeqMIw9zSrtVs2WyK-OudSbIplYriWyAnMJdzzZz5PoDnuJ_aRFlfnWDuCxSMTaxSTmIqHAu0OByLcN95NM6Gu2TrgB4swavFXZgGH6L74RYso_bXwcBPbb5-Dhr69ftZz4cjyq_ACskSHlR64_M5dhQXzRGCdwWxD0J0ASuU4PXu0wvBaCWs64_LMs2LiWsdeQbX4ctizE3DyUmvmuue-fkbnON_TuoGXGszUvS6UaGbsOSKW7A6as_cb8OedyeBKsWrZPACaJqjYxf6sOeTEm2is8msKlHNWYS81FForEE1rgNShUVtKzwqKx3--JRoUqCas_sO7A42d94O45aNITYBQiZWCic2DyRliorEJkYwTYjLrbbOl0GGeHuzqSI872OsqcgszVNmBDeaOq5YeheWi2nh7gPK-lYZbInTghLDEmEYcS5xhOlM834WwcvFtkjTQpUHxoxvsgFZxtKvk6zXKYJnnehpg89xmdCLem87CTU7CQ1tjMr98Tv5Jhl-2j_cGcntCNYWmy9bWy5lQGBjzJeFJIKn3WtvheFoRRVuWgUZGppx6V9kSMYDEHAE9xrF6gbks8yMCM78zGv1-PNc5NZor3548O-iT2B1e2MgP74ff3gIV33KR5suujVYns8q98inVXP9uDafX5xoGx8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroprevalence+of+hepatitis+E+virus+among+pregnant+women+and+control+subjects+in+China&rft.jtitle=Journal+of+medical+virology&rft.au=Cong%2C+Wei&rft.au=Sui%2C+Jian-Chao&rft.au=Zhang%2C+Xiang-Yan&rft.au=Qian%2C+Ai-Dong&rft.date=2015-03-01&rft.eissn=1096-9071&rft.volume=87&rft.issue=3&rft.spage=446&rft_id=info:doi/10.1002%2Fjmv.24058&rft_id=info%3Apmid%2F25164987&rft.externalDocID=25164987
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon